Drugs / BCG-Japan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT04383925 | May 2020 → Oct 2022 | cardiomyopathy, infantile hypertrophic | Bandim Health Project | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03400878 Comparator | Oct 2017 → Jun 2020 | — | Bandim Health Project | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG-Japan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03400878 ↗ |
| Modality | Vaccine | “BCG-Japan vaccine” NCT03400878 ↗ |
| Route | Other | “by intradermal injection in the left deltoid region.” NCT03400878 ↗ |